AMG 757
Showing 1 - 25 of 372
Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)
Not yet recruiting
- Small Cell Lung Cancer (SCLC)
- Tarlatamab
- +3 more
- (no location specified)
Feb 21, 2023
Small Cell Lung Carcinoma Trial in Worldwide (AMG 757, Pembrolizumab, CRS Mitigation Strategies)
Recruiting
- Small Cell Lung Carcinoma
- AMG 757
- +2 more
-
Duarte, California
- +34 more
Dec 6, 2022
Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)
Recruiting
- Extensive Stage Small Cell Lung Cancer
- Tarlatamab
- +4 more
-
Los Angeles, California
- +37 more
Feb 1, 2023
Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Small Cell Lung Cancer
- Tarlatamab
- Placebo
-
Minneapolis, Minnesota
- +124 more
Oct 31, 2023
Postmenopausal Osteoporosis Trial in Korea, Republic of (Romosozumab, Placebo)
Completed
- Postmenopausal Osteoporosis
- Romosozumab
- Placebo
-
Busan, Korea, Republic of
- +9 more
Sep 23, 2019
Systemic Lupus Erythematosus Trial in Evansville, Overland Park, Madison (AMG 570, AMG 570 Matching Placebo)
Completed
- Systemic Lupus Erythematosus
- AMG 570
- AMG 570 Matching Placebo
-
Evansville, Indiana
- +2 more
Sep 20, 2021
Obesity Trial in United States (K-757 and K-833, K-757 and matching to K-833, Matching to K-757 and matching to K-833)
Not yet recruiting
- Obesity
- K-757 and K-833
- +2 more
-
San Diego, California
- +18 more
Aug 25, 2023
Obesity, Type 2 Diabetes in Obese Trial in Newark (K-757 and K-833, Matching to K-757 and K-833)
Active, not recruiting
- Obesity
- Type 2 Diabetes Mellitus in Obese
- K-757 and K-833
- Matching placebo to K-757 and K-833
-
Newark, DelawareQPS, LLC
Jun 6, 2023
Relapsed/Refractory Small Cell Lung Cancer Trial in Worldwide (Tarlatamab)
Recruiting
- Relapsed/Refractory Small Cell Lung Cancer
-
Birmingham, Alabama
- +78 more
Jan 18, 2023
Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)
Active, not recruiting
- Relapsed/Refractory Multiple Myeloma
- AMG 701
- +2 more
-
Scottsdale, Arizona
- +33 more
Nov 29, 2022
Healthy Subjects Trial in Madison (AMG 510)
Completed
- Healthy Subjects
- AMG 510
-
Madison, WisconsinCovance Clinical Research Unit, Inc
Nov 3, 2022
Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)
Active, not recruiting
- Advanced Solid Tumors
- AMG 994
- AMG 404
-
Duarte, California
- +16 more
Nov 16, 2022
Healthy Volunteers Trial in Madison (AMG 510, Metformin)
Completed
- Healthy Volunteers
- AMG 510
- Metformin
-
Madison, WisconsinCovance Clinical Research Unit
Jan 9, 2023
MTAP-null Non-Small-Cell Lung Cancer, MTAP-null Solid Tumors Trial (AMG 193, IDE397)
Not yet recruiting
- MTAP-null Non-Small-Cell Lung Cancer
- MTAP-null Solid Tumors
- AMG 193
- IDE397
- (no location specified)
Jul 27, 2023
Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)
Completed
- Chronic Graft-versus-Host Disease (cGVHD)
- AMG 592
- Placebo
-
Randwick, New South Wales, AustraliaResearch Site
May 23, 2023
Heart Failure, Healthy Volunteer Trial in Worldwide (AMG 986 IV, AMG 986 PO, Placebo PO)
Terminated
- Heart Failure
- Healthy Volunteer
- AMG 986 IV
- +3 more
-
Anaheim, California
- +24 more
Mar 30, 2022
Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)
Completed
- Chronic Graft-versus-host Disease (cGVHD)
- AMG 592
- Placebo
-
Aventura, FloridaResearch Site
May 16, 2023
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Philadelphia, Greenville, San Antonio (AMG 820)
Completed
- Advanced Malignancy
- +5 more
- AMG 820
-
Philadelphia, Pennsylvania
- +2 more
Jan 18, 2023
Acceleromyography- and Electromyography-based Neuromuscular
Not yet recruiting
- Neuromuscular Blockade
- TOF-Watch®;DELSYS® Wireless surface EMG
-
Wuhan, Hubei, ChinaDepartment of Anaesthesiology, Tongji Hospital of Tongji Medical
Dec 15, 2022